SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001279569-18-001382
Filing Date
2018-06-28
Accepted
2018-06-28 17:22:46
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM F-3 tv497368_f3.htm F-3 362758
2 EXHIBIT 4.1 tv497368_ex4-1.htm EX-4.1 717072
3 EXHIBIT 5.1 tv497368_ex5-1.htm EX-5.1 21895
4 EXHIBIT 23.1 tv497368_ex23-1.htm EX-23.1 4081
5 GRAPHIC tv497368_ex23-1img1.jpg GRAPHIC 10828
6 GRAPHIC tv497368_ex23-1img2.jpg GRAPHIC 16746
7 GRAPHIC tv497368_img1.jpg GRAPHIC 17080
8 GRAPHIC tv497368_ex5-1img1.jpg GRAPHIC 9138
9 GRAPHIC tv497368_ex5-1img2.jpg GRAPHIC 17924
10 GRAPHIC tv497368_ex5-1img3.jpg GRAPHIC 6224
  Complete submission text file 0001279569-18-001382.txt   1215047
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: F-3 | Act: 33 | File No.: 333-225969 | Film No.: 18926403
SIC: 2834 Pharmaceutical Preparations